Search

To analyze the use of neuraxial techniques in total hip or knee arthroplasty patients who previously underwent lumbar spine surgeries. Retrospective analysis of a national database. U.S. hospitals. Patients undergoing a total hip or knee arthroplasty, stratified by those with a previous lumbar fusion or decompression procedure. Our primary outcome was the use of neuraxial anesthesia; secondary outcomes included combined complications, cardio-pulmonary complications, and prolonged length of stay. Patients with and without a history of a lumbar procedure were compared using mixed-effects regression. Among 758,857 THAs 8961 had a history of lumbar fusion and 8599 of decompression. Among 1,387,335 TKAs 15,827 had a history of lumbar fusion and 13,652 of decompression. History of a lumbar fusion was associated with lower odds of neuraxial anesthesia use in THA (OR: 0.74 CI: 0.70–0.79, p ≤0.0001) and TKA (OR: 0.80 CI: 0.77–0.84, p ≤0.0001). Previous lumbar fusion -but not decompression- surgery is associated with lower neuraxial anesthesia in THA/TKA patients, despite its use being universally associated with decreased length of stay. More research is needed to address the importance of neuraxial techniques in patients with prior spine surgery. • Lumbar procedures are common in the U.S. and are expected to increase in practice. • We analyzed more than 2.1 million patients undergoing total joint arthroplasty. • Only 15.6% of patients with previous lumbar fusion received neuraxial anesthesia. • History of a lumbar fusion was associated with lower odds of neuraxial anesthesia use. [ABSTRACT FROM AUTHOR]

Acetaminophen (APAP) and intravenous acetaminophen (IVAPAP) has been proposed as a part of many opioid-sparing multimodal analgesic pathways. The aim of this analysis was to compare the effectiveness of IVAPAP with oral APAP on opioid utilization and opioid-related adverse effects. Retrospective study of population-based database. The Premier Healthcare database was queried patients undergoing surgery for a primary diagnosis of hip fracture from 2011 to 2019 yielding 245,976 patients. Primary exposure was use of IVAPAP or oral APAP on the day of surgery. None. The primary outcome of interest was opioid utilization over the hospital stay, secondary outcomes included opioid-related adverse effects, length, and costs of hospital stay. Mixed effect models measured the association of IVPAP and APAP and outcomes. In the study population 30.67% (75,445) received at least 1 dose of IVAPAP on the day of surgery. Upon adjusting for relevant covariates, patients who received IVPAP on the day of surgery had slightly higher opioid use standardized by length of hospital stay (2.8% CI: 2%, 3.6%; p <.001), higher hospital cost (2.7% CI: 2.1%, 3.4%), and higher odds of naloxone use (1.18, CI: 1.1, 1.27; p <.001) when compared with patients who received oral APAP. In this population, IVAPAP use on the day of surgery failed to reduce opioid use or associated opioid related adverse effects when compared with oral APAP. IVAPAP was associated with increased overall costs, opioid requirements, and naloxone use. These results do not support the use of IV over oral APAP routinely for hip fracture surgery patients. • IVAPAP use on the day of surgery failed to reduce opioid related adverse effects when compared with oral APAP. • IVAPAP was associated with increased overall costs, opioid requirements, and naloxone use when compared with oral APAP. • These results do not support the use of IV over oral APAP routinely for hip fracture surgery patients. [ABSTRACT FROM AUTHOR]

• Significant racial difference exists in the provision of regional anesthesia and analgesia. • Hospitals with a low volume of joint arthroplasties tended to serve a relative larger proportion of minority patients. • Our data suggest a potential role of hospital-specific factors as targets to reduce these disparities. [ABSTRACT FROM AUTHOR]